ExodusPoint Capital Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05M | Buy |
+289,528
| New | +$1.05M | 0.01% | 888 |
|
|
2024
Q4 | – | Sell |
-133,934
| Closed | -$177K | – | 1338 |
|
|
2024
Q3 | $177K | Buy |
+133,934
| New | +$177K | ﹤0.01% | 1355 |
|
|
2024
Q2 | – | Sell |
-137,742
| Closed | -$252K | – | 1348 |
|
|
2024
Q1 | $252K | Sell |
137,742
-105,232
| -43% | -$193K | ﹤0.01% | 1179 |
|
|
2023
Q4 | $301K | Buy |
+242,974
| New | +$301K | ﹤0.01% | 1109 |
|
|
2022
Q2 | – | Sell |
-224,537
| Closed | -$161K | – | 1844 |
|
|
2022
Q1 | $161K | Buy |
224,537
+64,033
| +40% | +$45.9K | ﹤0.01% | 1886 |
|
|
2021
Q4 | $363K | Buy |
160,504
+5,164
| +3% | +$11.7K | ﹤0.01% | 1540 |
|
|
2021
Q3 | $447K | Sell |
155,340
-38,983
| -20% | -$112K | 0.01% | 1413 |
|
|
2021
Q2 | $736K | Buy |
194,323
+109,671
| +130% | +$415K | 0.01% | 1096 |
|
|
2021
Q1 | $287K | Buy |
84,652
+66,526
| +367% | +$226K | ﹤0.01% | 1661 |
|
|
2020
Q4 | $51K | Buy |
+18,126
| New | +$51K | ﹤0.01% | 1797 |
|